On the last day of 2012, the FDA approved 2 new drugs:
Fulyzaq (crofelemer) to relieve symptoms of diarrhea in HIV/AIDS patients taking antiretroviral therapy, a combination of medicines used to treat HIV infection. Fulyzaq is distributed by Salix Pharmaceuticals, based in Raleigh, N.C. under license from Napo Pharmaceuticals, Inc.
Sirturo (bedaquiline) as part of combination therapy to treat adults with multi-drug resistant pulmonary tuberculosis (TB) when other alternatives are not available. Sirturo is manufactured by Janssen Therapeutics, a division of Janssen Products LP, based in Titusville, N.J.
No comments:
Post a Comment